glp 1 benefits and risks GLP-1 Drugs Use, Risks, Regulation Know more :https://pib.gov.in/PressReleasePage.aspx?PRID=2247459 Schematic overview of the benefits

In-class differences were noticed especially related to heart failure (HF) and are discussed later in this manuscript

Sone H, Tanaka S, Tanaka S, Iimuro S, Oida K, Yamasaki Y, et al

Liraglutide dosing protocol Liraglutide for weight management (Saxenda) follows a 5-week titration schedule to the target dose of 3.0mg daily: Week 1: 0.6mg once daily Week 2: 1.2mg once daily Week 3: 1.8mg once daily Week 4: 2.4mg once daily Week 5 onward: 3.0mg once daily (maintenance) Each dose increase happens weekly, with the option to delay an increase for an additional week if side effects are difficult to manage

2017) reported that ATRA slightly increased intracellular levels of Nrf2, though the cytoprotective effect of ATRA putatively arose independently to Nrf2 signaling

This phenomenon is also observed in animal disease models